MAPT and Alzheimer disease: In an Aβ1–42 mouse-model of AD, Ahmad et al. were able to show that fisetin significantly decreased the Aβ1–42-induced accumulation of Aβ, BACE-1 expression, and hyperphosphorylation of tau protein.